Organon & Co.
OGN
$13.31
-$0.02-0.15%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 146.00M | -205.00M | 160.00M | 145.00M | 87.00M |
| Total Depreciation and Amortization | 86.00M | 96.00M | 92.00M | 89.00M | 84.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.00M | 284.00M | 39.00M | 47.00M | 29.00M |
| Change in Net Operating Assets | 42.00M | -34.00M | -27.00M | -61.00M | -125.00M |
| Cash from Operations | 225.00M | 141.00M | 264.00M | 220.00M | 75.00M |
| Capital Expenditure | -37.00M | -45.00M | -46.00M | -39.00M | -32.00M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 1.00M | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -75.00M |
| Divestitures | 433.00M | -- | -- | -- | -- |
| Other Investing Activities | -10.00M | -20.00M | -69.00M | 0.00 | -65.00M |
| Cash from Investing | 386.00M | -65.00M | -115.00M | -38.00M | -172.00M |
| Total Debt Issued | -- | 325.00M | 300.00M | 340.00M | 90.00M |
| Total Debt Repaid | -32.00M | -507.00M | -372.00M | -541.00M | -93.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.00M | -1.00M | -1.00M | -12.00M | -1.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.00M | -4.00M | -3.00M | -10.00M | -71.00M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -38.00M | -187.00M | -76.00M | -223.00M | -75.00M |
| Foreign Exchange rate Adjustments | -31.00M | 13.00M | 0.00 | 93.00M | 44.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 542.00M | -98.00M | 73.00M | 52.00M | -128.00M |